Logo-ipp

Original

1. Evaluation of the feasibility of using weekly paclitaxel as neoadjuvant therapy in patients with epithelial ovarian cancer; a pre-post clinical trial
Sakineh Ebrahimi ORCID, Seyed Saeed Hashemi Nazari ORCID, Arash Dooghaie Moghadam ORCID, Shirin Haghighi* ORCID
Immunopathol Persa. 2021;7(1): e09. doi: 10.34172/ipp.2021.09
Scopus ID: 85105074111    
Article
PDF
XML
Cited By:
1
1